References
- 1. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-810.
- 2. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762-774.
- 3. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377.
- 4. Shum HP, Leung YW, Lam SM, Chan KC, Yan WW. Alteco endotoxin hem adsorption in gram-negative septic shock patients. Indian J Crit Care Med. 2014;18(12):783-788.
- 5. Esteban E, Ferrer R, Alsina L, Artigas A. Immunomodulation in sepsis: The role of endotoxin removal by polymyxin B-immobilized cartridge. Mediators Inflamm. 2013;2013:507539.
- 6. Buttenschoen K, Radermacher P, Bracht H. Endotoxin elimination in sepsis: Physiology and therapeutic application. Langenbeck’s Archives of Surgery. 2010;395(6):597-605.
- 7. Arias-Verdu D, Herrera Gutierrez M, Seller-Perez G, Benitez- Moreno P, Aguiar-Flores E, Quesada-Garcia G. Comparison of two different adsorptive therapies for the treatment of endotoxemia. . 2012;38:S286-S286.
- 8. Adamik B, Zielinski S, Smiechowicz J, Kübler A. Endotoxin elimination in patients with septic shock: An observation study. Arch Immunol Ther Exp (Warsz ). 2015;63(6):475-483.
- 9. Andersen TH, Jensen TH, Andersen LW. Adjunctive therapy of severe sepsis and septic shock in adults. Current Anaesthesia & Critical Care. 2009;20(5-6):254-258.
- 10. Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: A systematic review. Critical Care. 2007;11(2):1.
- 11. Ala-Kokko TI, Laurila J, Koskenkari J. A new endotoxin adsorber in septic shock: Observational case series. Blood Purif. 2011;32(4):303-309.
- 12. Kulabukhov V. Use of an endotoxin adsorber in the treatment of severe abdominal sepsis. Acta Anaesthesiol Scand. 2008;52(7):1024-1025.
- 13. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-inimobilized fiber. The American Journal of Surgery. 1994;167(4):412-417.
- 14. Garidel P, Brandenburg K. Current understanding of polymyxin B applications in bacteraemia/sepsis therapy prevention: Clinical, pharmaceutical, structural and mechanistic aspects. Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Infective Agents). 2009;8(4):367-385.
- 15. Payen DM, Guilhot J, Launey Y, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: A multicenter randomized control trial. Intensive Care Med. 2015;41(6):975-984.
- 16. Yaroustovsky M, Plyushch M, Popov D, et al. Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery. J Inflamm. 2013;10(1):1.
- 17. Yaroustovsky M, Abramyan M, Popok Z, et al. Preliminary report regarding the use of selective sorbents in complex cardiac surgery patients with extensive sepsis and prolonged intensive care stay. Blood Purif. 2009;28(3):227-233.
- 18. Harm S, Falkenhagen D, Hartmann J. Endotoxin adsorbents in extracorporeal blood purification: Do they fulfill expectations? Int J Artif Organs. 2014;37(3):222-232.
- 19. Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: A meta-analysis of randomized trials. Crit Care Med. 2013;41(9):2209-2220.